#371 – Women's sexual health: desire, arousal, and orgasms, navigating perimenopause, and enhancing satisfaction | Sally Greenwald, M.D., M.P.H.

Episode Summary

Executive Summary: Peter Attia interviews Dr. Sally Greenwald about women’s sexual health as a core component of overall health, longevity, and relationship quality. They cover anatomy, desire, orgasm, lubrication, pain, menopause/perimenopause, contraception, medications, trauma, pregnancy/postpartum, and sex education—arguing that sexual function is highly individualized, often misunderstood, and improvable with education, hormones, devices, and communication.

Main Topics: Sexual health as longevity and overall health (Priority: 5/5): The episode frames sexual well-being as a legitimate health domain tied to sleep, mood, cardiovascular function, relationships, and quality of life across the lifespan. Desire, arousal, and the accelerator-brake model (Priority: 5/5): Greenwald explains spontaneous vs responsive desire, and how hormones, neurotransmitters, stress, and relational context influence arousal in women. Female anatomy, orgasm, and the orgasm gap (Priority: 5/5): The discussion demystifies clitoral/vaginal anatomy, orgasm phases, foreplay timing, and why many women do not orgasm from penetrative intercourse alone. Lubrication, vaginal health, and pain with sex (Priority: 5/5): They discuss vaginal lubrication sources, why lube is broadly beneficial, moisturizer options, local estrogen, and the pain cycle that can lead to dyspareunia/vaginismus. Perimenopause, menopause, and contraception choices (Priority: 5/5): A large segment focuses on choosing therapies based on whether a woman wants to ovulate, and how estrogen/progestin/testosterone or contraceptives affect symptoms and desire. Pharmacologic and behavioral tools for low desire (Priority: 4/5): They review FDA-approved drugs, testosterone, cannabis, vibrators, pelvic floor therapy, mindfulness, and scheduling sex as practical interventions. Trauma, pregnancy/postpartum, and sexual education (Priority: 4/5): The conversation covers trauma-informed care, cancer survivorship, pregnancy safety, postpartum hypoestrogenism, and the need for better anatomy- and pleasure-based sex education.

Key Arguments: Sexual health is not optional or secondary; it should be treated as part of health and longevity, alongside sleep, exercise, and disease prevention. Women’s desire is often responsive rather than spontaneous, so arousal may need to be intentionally cultivated through context, foreplay, lubrication, and reduced pressure. Orgasm in women is highly variable and often not tied to penetrative intercourse; most women need external clitoral stimulation or other adjuncts. Pain with sex is common and self-reinforcing; early use of adequate lubrication, moisturizers, local estrogen, and pelvic floor therapy can prevent chronic dysfunction. Perimenopause treatment should start by asking whether the patient likes ovulating, because symptom burden and preferred treatment depend on that preference. Contraception, menopause hormone therapy, and testosterone can each help or hinder desire depending on formulation, dose, and individual response. FDA-approved low-desire medications have limited efficacy and side effects; testosterone plus behavioral strategies may be more practical for many patients. Trauma-informed, anatomy-based sexual education is needed because porn and fear-based teaching create unrealistic expectations and poor sexual literacy.

Data Points: Couples having sex twice weekly or more: ~20% - Reported frequency among couples ages 30-60 Couples having sex never (past year): ~10% - Reported frequency among couples ages 30-60 Couples having sex between once and twice a month: ~70% - Reported frequency among couples ages 30-60 Women with spontaneous desire: ~15% - Greenwald says spontaneous desire is less common in women than responsive desire Women orgasming with a male partner always: ~30% - Compared with men’s near-universal orgasm rate in partnered sex Women orgasming on a one-night stand with a man: ~12% - Used to illustrate orgasm disparity Men orgasming with a female partner almost every time: ~95% - Benchmark used in orgasm-gap discussion Men orgasming on a one-night stand: ~90% - Used for comparison with female orgasm rates Average time to orgasm alone: <4 minutes - Average for women when alone Average time to orgasm with a partner: ~21-25 minutes - Average for women in partnered sex Women orgasming after foreplay >21 minutes: >90% - Time-dependent effect of foreplay on orgasm likelihood Women experiencing pain with intercourse: ~30% - Used to justify lubrication and pelvic floor attention Clitoral nerve roots: >8,000 - Anatomical detail used to explain sensitivity and orgasm pathways Women able to orgasm from internal/anterior clitoral branch stimulation: ~10% - Described as the minority pathway, while the majority require external stimulation Women who orgasm from penetrative intercourse alone: <10% - Without external clitoral stimulation Sexual health consults involving a male partner: ~20% - Greenwald’s clinic frequency for couple-based consults Women who prefer not to ovulate in perimenopause: ~70-80% - Her patient-panel estimate for symptom-driven treatment choice Women whose sex drive improved after ovulation suppression: 20% - From a meta-analysis of 32 trials Women with no change in sex drive after ovulation suppression: 65% - From the same meta-analysis Women whose sex drive decreased after ovulation suppression: 15% - From the same meta-analysis Trials in ovulation-suppression meta-analysis: 32 - Meta-analysis cited on contraception and sex drive Women included in ovulation-suppression meta-analysis: >14,000 - Population size across trials TT + menopause-related suppression threshold: Total testosterone >20 ng/dL target floor - Greenwald’s practical treatment floor before symptom-guided titration Total testosterone range of interest: 20-80 ng/dL - Approximate range where she monitors symptoms and response Addyi efficacy: +1 satisfying sexual encounter/month - In the approval trial compared with placebo THC dose for sexual benefit: ~1-2 mg - Dose range Greenwald says is often associated with improved sexual experience THC adverse effect threshold: Higher doses can be sedating - Explains inverse dose-response and reduced desire at larger doses Contraceptive pill cost with natural estradiol option: ~$100/month - Approximate out-of-pocket cost when insurance does not cover it Breastfeeding/postpartum interval guidance: 18 months - ACOG spacing recommendation between pregnancies Postpartum return to sex: 6 weeks - Standard recommendation after vaginal birth or C-section absent complications High school students in sex-debut study: 1,200 - Study showing boys framed debut around pleasure and girls around pain Boys reporting pleasure-related first-sex responses: 70% - Sex education and expectation-setting point Girls reporting pain-related first-sex responses: 70% - Shows need for better education and lubrication/foreplay guidance Women who can safely vary vaginal activity after sex therapy stages: 4-step sensate focus model - Intimacy progression: non-genital touch, genital touch without orgasm, orgasm without penetration, then penetration

Pivotal Quotes: "sexual health is health" — Dr. Sally Greenwald: Core thesis of the episode and justification for including sex in longevity medicine "You do not want to ovulate. Let's make this go away." — Dr. Sally Greenwald: Summarizing the key branching question she uses in perimenopause treatment "if you're listening to this podcast and you want to work on your desire, if you're waiting for your husband to get a new shirt or a new car, the visual stimulus is not evidence-based. Stop waiting for that." — Dr. Sally Greenwald: Explaining that women’s desire is usually responsive, not triggered by simple visual cues

Implications: Listeners should treat sexual health as learnable, treatable, and integral to longevity. Clinicians may need to ask more specific questions, use anatomy-based education, and personalize hormones, contraception, and adjuncts rather than defaulting to one-size-fits-all care.